Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% |
|
0.00% | +14.29% |
Jun. 26 | Appili Therapeutics Q4 Loss Narrows Amid Increase in Government Assistance | MT |
Jun. 26 | Appili Therapeutics Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Business Summary
Number of employees: 9
Sales per Business
CAD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +147.60% |
Sales per region
CAD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +147.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Kenneth Howling
DFI | Director of Finance/CFO | 66 | 21-11-15 |
Carl Gelhaus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leona Saunders
LAW | General Counsel | - | - |
Myriam Triest
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 19-09-30 | |
Gary Nabors
PRN | Corporate Officer/Principal | - | 23-04-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 20-01-26 | |
Prakash Gowd
BRD | Director/Board Member | 60 | Nov. 12 |
Director/Board Member | 70 | 21-02-01 | |
Brian Bloom
BRD | Director/Board Member | 48 | 15-05-06 |
Director/Board Member | 56 | 18-09-30 | |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 121,266,120 | 121,191,120 ( 99.94 %) | 0 | 99.94 % |
Company contact information
Appili Therapeutics, Inc.
1344 Summer Street Suite 21
B3H 0A8, Halifax
+
http://www.appilitherapeutics.com![address Appili Therapeutics Inc.(APLI)](https://cdn.zonebourse.com/static/address/60546364.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+14.29% | 3.56M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.76% | 25.93B | |
-24.33% | 19.27B | |
-19.37% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- APLI Stock
- Company Appili Therapeutics Inc.